668 related articles for article (PubMed ID: 27109327)
1. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
2. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
3. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
4. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
[TBL] [Abstract][Full Text] [Related]
5. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
6. Lithium and clozapine rechallenge: a retrospective case analysis.
Kanaan RA; Kerwin RW
J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
[TBL] [Abstract][Full Text] [Related]
7. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
[TBL] [Abstract][Full Text] [Related]
8. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
9. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
Manu P; Lapitskaya Y; Shaikh A; Nielsen J
Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-induced neutropenia in children: management with lithium carbonate.
Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
[TBL] [Abstract][Full Text] [Related]
11. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
Dunk LR; Annan LJ; Andrews CD
Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
[TBL] [Abstract][Full Text] [Related]
12. Continuing clozapine treatment despite neutropenia.
Esposito D; Rouillon F; Limosin F
Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
[TBL] [Abstract][Full Text] [Related]
13. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
Silva E; Higgins M; Hammer B; Stephenson P
BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
[TBL] [Abstract][Full Text] [Related]
14. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
[TBL] [Abstract][Full Text] [Related]
15. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
16. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
17. G-CSF plasma levels in clozapine-induced neutropenia.
Jauss M; Pantel J; Werle E; Schröder J
Biol Psychiatry; 2000 Dec; 48(11):1113-5. PubMed ID: 11094146
[TBL] [Abstract][Full Text] [Related]
18. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report.
Crépeau-Gendron G; L'Heureux S
Early Interv Psychiatry; 2015 Apr; 9(2):151-5. PubMed ID: 24690066
[TBL] [Abstract][Full Text] [Related]
20. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
